FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> H. Lundbeck | Lundbeck | Elan

Lundbeck CFO squelches Elan takeover buzz

Shares of Ireland's Elan have been gyrating in recent months over persistent market buzz about a potential takeover bid by Lundbeck. But Lundbeck CFO Anders Gotzsche squelched the rumors today, saying that he didn't see how the company could raise enough cash for that kind of a deal.

Elan hired Citigroup back in January for a strategic review that could include a sale or merger. And soon after Copenhagen-based Lundbeck emerged as a likely bidder.

"I don't see that, at this point in time, it would be possible to borrow the money needed to buy a company the size of Elan," Gotzsche told Reuters. Elan's shares were down about five percent this morning.

- read the report from Reuters

Related Articles:
Elan's stock rises on rumor of Lundbeck bid
Elan cuts 230 jobs as it waits for trial results
Investors revolt to block Elan sale
Elan deal rumors fly; investors not enthused
Elan triggers strategic review, spurring merger buzz


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about H. Lundbeck   Lundbeck   Elan